Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke Onset
This trial tests whether intravenous tenecteplase thrombolysis initiated between 4.5 and 24 hours after symptom onset benefits patients with acute ischemic stroke due to non–large vessel occlusion with evidence of salvageable brain tissue.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.